Balance Sheet
Cash Flow Statement
AmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Change in Receivables (2016 - 2022)

RedHill Biopharma has reported Change in Receivables over the past 7 years, most recently at $1.5 million for Q4 2022.

  • Quarterly Change in Receivables rose 190.55% to $1.5 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2022, up 82.5% year-over-year, with the annual reading at -$2.9 million for FY2025, 271.54% down from the prior year.
  • Change in Receivables was $1.5 million for Q4 2022 at RedHill Biopharma, up from -$2.3 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $6.1 million in Q3 2020 and troughed at -$16.2 million in Q4 2020.
  • The 5-year median for Change in Receivables is -$52500.0 (2019), against an average of -$248800.0.
  • The largest YoY upside for Change in Receivables was 5487.27% in 2020 against a maximum downside of 17367.02% in 2020.
  • A 5-year view of Change in Receivables shows it stood at $474000.0 in 2018, then plummeted by 80.17% to $94000.0 in 2019, then tumbled by 17367.02% to -$16.2 million in 2020, then skyrocketed by 89.9% to -$1.6 million in 2021, then skyrocketed by 190.55% to $1.5 million in 2022.
  • Per Business Quant, the three most recent readings for RDHL's Change in Receivables are $1.5 million (Q4 2022), -$2.3 million (Q3 2022), and $718000.0 (Q2 2022).